CD69 and myeloid sarcoma: In a heterogeneous group of subjects, GrK was more abundant in brain CD103–CD69+CD8+ T cells than CD103+CD69+CD8+ cells populations, but most brain donors had no neurological disease or were patients with MS or Parkinson’s diseases and no data could be correlated with AD16.